Legislation & Regulation

Discover essential legislative and regulatory resources tailored for managed care pharmacy professionals. Stay informed with the latest updates, policies, and advocacy tools to effectively navigate and influence the health care landscape.

Learn More

Legislative & Regulatory Briefings

November 2023 Legislative & Regulatory Briefing

November 2023 Legislative & Regulatory Briefing: AMCP’s Adam Colborn Gives a Legislative, Regulatory, and Judiciary Update on Trending Topics in the Pharmacy Space; AMCP Comments on Requirements Related to the Mental Health Parity and Addiction Act; Now Available: Key Takeaways from AMCP’s Aug. 2 IRA Workshop Kickoff; AMCP Comments on Discrimination on the Basis of Disability in HHS Programs or Activities; AMCP Celebrates America’s Managed Care Pharmacists During National Pharmacy Month; Register Now: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Webinar.
Legislation & Regulation
AMCP Caragon
Legislative & Regulatory Briefings

November 2023 Legislative & Regulatory Briefing

November 2023 Legislative & Regulatory Briefing: AMCP’s Adam Colborn Gives a Legislative, Regulatory, and Judiciary Update on Trending Topics in the Pharmacy Space; AMCP Comments on Requirements Related to the Mental Health Parity and Addiction Act; Now Available: Key Takeaways from AMCP’s Aug. 2 IRA Workshop Kickoff; AMCP Comments on Discrimination on the Basis of Disability in HHS Programs or Activities; AMCP Celebrates America’s Managed Care Pharmacists During National Pharmacy Month; Register Now: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Webinar.
Legislation & Regulation
Letters, Statements & Analysis

AMCP Comment on Discrimination on the Basis of the Disability in Health and Human Service Programs or Activities

On September 14, 2023, the Department of Health and Human Services (HHS) and the Office for Civil Rights issued the proposed rule titled “Discrimination on the Basis of the Disability in Health and Human Service Programs or Activities". AMCP submitted comments in response to the proposed rule on November 13, 2023.
Legislation & Regulation
Legislative & Regulatory Briefings

October 2023 Legislative & Regulatory Briefing

October 2023 Legislative & Regulatory Briefing: Now Available: “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy”; AMCP Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plan; AMCP Makes Headlines on PDTs, Nexus 2023; BBCIC Awarded $1.4 Million Grant From the FDA; AMCP Comments on Medicaid Program; Misclassification of Drugs, Program Administration, and Program Integrity Updates Under the Medicaid Drug Rebate Program.
Legislation & Regulation
AMCP Caragon
Legislative & Regulatory Briefings

October 2023 Legislative & Regulatory Briefing

October 2023 Legislative & Regulatory Briefing: Now Available: “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy”; AMCP Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plan; AMCP Makes Headlines on PDTs, Nexus 2023; BBCIC Awarded $1.4 Million Grant From the FDA; AMCP Comments on Medicaid Program; Misclassification of Drugs, Program Administration, and Program Integrity Updates Under the Medicaid Drug Rebate Program.
Legislation & Regulation
AMCP 2023 Value of Managed Care Pharmacy Report
Resource

The Value of Managed Care Pharmacy

Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.
Biosimilars, Prescription Digital Therapeutics, Formulary & Utilization Management, Health Disparities, Health Technology, Legislation & Regulation, Managed Care Practice Issues
Letters, Statements & Analysis

AMCP Comment on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans

On August 21, 2023, CMS Issued the Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025. The purpose of this document is to provide interested parties with draft part one guidance on a select set of topics for the Maximum Monthly Cap on Cost-Sharing Payments Program.
Legislation & Regulation
Legislative & Regulatory Briefings

September 2023 Legislative & Regulatory Briefing

September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.
Legislation & Regulation